Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial
GBG Forschungs GmbH
Sibylle Loibl; Frederik Marmé; Miguel Martin; Michael Untch; Hervé Bonnefoi; Sung-Bae Kim; Harry Bear; Nicole McCarthy; Mireia Melé Olivé; Karen Gelmon; José García-Sáenz; Catherine M Kelly; Toralf Reimer; Masakazu Toi; Hope S Rugo; Carsten Denkert; Michael Gnant; Andreas Makris; Maria Koehler; Cynthia Huang-Bartelett; Maria Jose Lechuga Frean; Marco Colleoni; Gustavo Werutsky; Sabine Seiler; Nicole Burchardi; Valentina Nekljudova; Gunter von Minckwitz